Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ben Goldacre"'
Autor:
The OpenSAFELY Collaborative, Angel Y. S. Wong, Laurie A. Tomlinson, Jeremy P. Brown, William Elson, Alex J. Walker, Anna Schultze, Caroline E. Morton, David Evans, Peter Inglesby, Brian MacKenna, Krishnan Bhaskaran, Christopher T. Rentsch, Emma Powell, Elizabeth Williamson, Richard Croker, Seb Bacon, William Hulme, Chris Bates, Helen J. Curtis, Amir Mehrkar, Jonathan Cockburn, Helen I. McDonald, Rohini Mathur, Kevin Wing, Harriet Forbes, Rosalind M. Eggo, Stephen J. W. Evans, Liam Smeeth, Ben Goldacre, Ian J. Douglas
Publikováno v:
Journal of Hematology & Oncology
Wong, A Y S, Tomlinson, L A, Brown, J P, Elson, W, Walker, A J, Schultze, A, Morton, C E, Evans, D, Inglesby, P, MacKenna, B, Bhaskaran, K, Rentsch, C T, Powell, E, Williamson, E, Croker, R, Bacon, S, Hulme, W, Bates, C, Curtis, H J, Mehrkar, A, Cockburn, J, McDonald, H I, Mathur, R, Wing, K, Forbes, H, Eggo, R M, Evans, S J W, Smeeth, L & Goldacre, B & Douglas, I J 2021, ' Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants : population-based cohort study ', Journal of Hematology and Oncology, vol. 14, no. 1, 172 . https://doi.org/10.1186/s13045-021-01185-0
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-10 (2021)
Wong, A Y S, Tomlinson, L A, Brown, J P, Elson, W, Walker, A J, Schultze, A, Morton, C E, Evans, D, Inglesby, P, MacKenna, B, Bhaskaran, K, Rentsch, C T, Powell, E, Williamson, E, Croker, R, Bacon, S, Hulme, W, Bates, C, Curtis, H J, Mehrkar, A, Cockburn, J, McDonald, H I, Mathur, R, Wing, K, Forbes, H, Eggo, R M, Evans, S J W, Smeeth, L & Goldacre, B & Douglas, I J 2021, ' Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants : population-based cohort study ', Journal of Hematology and Oncology, vol. 14, no. 1, 172 . https://doi.org/10.1186/s13045-021-01185-0
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-10 (2021)
Background Thromboembolism has been reported as a consequence of severe COVID-19. Although warfarin is a commonly used anticoagulant, it acts by antagonising vitamin K, which is low in patients with severe COVID-19. To date, the clinical evidence on
Publikováno v:
BJGP Open
BJGP Open, Vol 5, Iss 4 (2021)
BJGP Open, Vol 5, Iss 4 (2021)
BackgroundAntidepressants are commonly prescribed. There are clear national guidelines in relation to treatment sequencing. This study examines trends and variation in antidepressant prescribing across English primary care.AimTo examine trends and va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41b656dce0622d88210acad58acd9f51
https://researchonline.lshtm.ac.uk/id/eprint/4663760/1/BJGPO.2021.0020.full.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4663760/1/BJGPO.2021.0020.full.pdf
Publikováno v:
The British Journal of General Practice
BackgroundPrescribing high doses of methotrexate increases the potentially fatal risk of toxicity. To minimise risk, it is recommended that only 2.5 mg tablets are used.AimTo describe trends in GP prescribing of methotrexate over time; the harm assoc
Publikováno v:
BMJ Open
ObjectiveTo assess the benefits and harms of pregabalin in the management of neuropathic pain.DesignRapid review and meta-analysis of phase III, randomised, placebo-controlled trials.ParticipantsAdults aged 18 years and above with neuropathic pain de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d50a6ea8760f3460d5344695b9235351
https://doi.org/10.1136/bmjopen-2018-023600
https://doi.org/10.1136/bmjopen-2018-023600
Publikováno v:
The BMJ
ObjectivesTo determine how clinicians vary in their response to new guidance on existing or new interventions, by measuring the timing and magnitude of change at healthcare institutions.DesignAutomated change detection in longitudinal prescribing dat
Publikováno v:
BMJ Open
ObjectivesFollowing litigation over pregabalin’s second-use medical patent for neuropathic pain NHS England were required by the court to instruct GPs to prescribe the branded form (Lyrica) for pain. Pfizer’s patent was found invalid in 2015; a r